News archive
Video interview (in Swedish) with CEO Dorte X. Gram by ‘Invest Talks’
Watch the interview in Swedish here
(12-Mar-2021)
Development of a novel drug to treat diabetes.
Investor presentation by CEO Dorte X. Gram at the BioStock Life Science Summit 2020, Lund, Sweden.
Watch the presentation in English here
(17-Nov-2020)
The Malmö-based company Pila Pharma, which has a drug candidate for type 2 diabetes, will be listed on one of the Swedish stock exchanges in the second quarter of next year.
Read the article in Swedish here
(17-Nov-2020)
Pila Pharma has scheduled its arrival on the Swedish stock market for May next year with the goal of fetching SEK 50m for developing the firm’s diabetes tablet leading up to phase III.
An interview with CEO Dorte X. Gram by Medwatch, Denmark.
Read the article in English here
Read the article in Danish here
(17-Nov-2020)
Our Opinion and Concept Paper on the role of TRPV1 in diabetes published in Trends in Molecular Medicine.
Read the paper here
(November 2017)
Novo-forsker gjorde ph.d.-projekt til biotekselskab og forbereder nu fase 2-studie.
An interview with CEO Dorte X. Gram by Medwatch, Denmark.
Read the article in Danish here
(1 January 2019)
Om jag har rätt kan detta bli gigantisk.
An interview with CEO Dorte X. Gram by BioStock, Sweden.
Read the article in Swedish here
PILA PHARMA är klar med uppstartsfasen och flyttar ut från inkubatorn.
An interview with CEO Dorte X. Gram published by Medeon, Sweden.
Read the article in Swedish here
Nytt piller skal göra livet lättare för diabetiker – svensk bolag vill förändra sjukvården.
An interview with CEO Dorte X. Gram published in Veckans Affärer, Sweden.
Winning prize to PILA PHARMA at the Almi Invest pitch competition 2016, sponsored by Veckans Affärer.
Check out the resulting article here
Uppstickaren som vill ta plats i läkemedelsindustrin.
An interview with CEO Dorte X. Gram published in ‘DI Almedalen, Distributed with Dagens Industri, Sweden.
Read the article in Swedish here
We are proud to be on the cover of the June 2017 issue of Affärslivet Norden, Medicine and Science magazine that focuses on innovation.
The magazine was distributed with Svenska Dagbladet.
Read the article in Swedish here
“Min uppfinning kom och hämtade tillbaka mig”
Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by Sydsvenskan, Sweden.
Read the article in Swedish here
After ten years of diabetes R&D at Novo Nordisk, Dorte X. Gram took her findings and work further to start something on her own. As founder and CEO of PILA PHARMA she hopes to bring a new oral anti-diabetic agent to the market.
Read the article here
Development of a novel drug to treat diabetes.
Investor presentation by CEO Dorte X. Gram at the BioStock Life Science Summit 2018, Lund, Sweden.
Watch the presentation in English here
(25-Oct-2018)
We’re very pleased to share PILA PHARMA AB‘s new Youtube channel.
The first film shows a guest lecture at Prague University in September 2017 where CEO Dorte X. Gram talked to students about starting up a biotech company.
Watch the video here
(04-Sep-2017)
At BioEurope Spring in Stockholm in April 2016 Dr. Dorte X. Gram, CEO of PILA PHARMA was interviewed by the organizers about the current status and our plans going forward.
Please find the links below:
partnering360.com
(08-Apr-2016)
PILA PHARMA yesterday won the title “Årets pitchare 2016” at the ALMI Invest Seed Day in Stockholm, Sweden!
The 1-min pitch competition was held amongst 17 selected out of ALMI Invests 400 portfolio companies.
(06-Dec-2016)
In order to maximise the chance of getting to the final, I chose to do an alternative type of pitch to describe the ALMI-PILA history as well as the content of the project (indirectly).
At the final I did ‘the usual stuff’ with market size, potential return of investment and potential exit value (potentially in the unicorn league).
I’m very proud that the audience yesterday selected me and PILA PHARMA as winner of the title ‘Årets pitchare 2016’ at the ALMI Invest Seed Day!
ALTERNATIVE PITCH by PILA PHARMA:
Tack Sverige för ett fantastisk inkubator och innovations system!
Tack Malmö för ett häftigt uppstarts och tillväxt miljö!
— Forza Malmö, eller hur, Per?
Tack Per Antonsson, ALMI Invest Syd, för att du inte tröttnade på min mejl-storm om min teori!
Tack Universum för att Per hade förmåga att förstå teorin och att inse hur STORT det skulle kunna bli om man kan bota diabetes genom att blokera chili-receptorn!
Tack ALMI Invest för att ni vågade satsa på min kostnads-effektiva plan om snabb klinisk bevis för min diabetes tablet – och sen exit!
Tack befintliga och kommande investerare för att ni inte bara vil tjäna masser med pengar men också vil göra något bra för samhället och vara med om att slå ihjäl det stora diabetes-monster!
Tack!
